30 reports

  • Erythropoietin: An overview
  • Second-generation erythropoietin formulation
  • Erythropoietin
  • China
  • Forecast
  • Amgen Inc.
  • Kyowa Hakko Kirin Co., Ltd.

Introduction to Erythropoietin ##. ## An Introduction to Erythropoietin ##. ##. ##.

  • Biopharmaceutical
  • Erythropoietin
  • World
  • Market Size

Erythropoietin Drug Market Outlook, By Region (2014-2022) ($MN) Table ## Global Erythropoietin Drug Market Outlook, By Product (2014-2022) ($MN) Table ## Global Erythropoietin Drug Market Outlook, By Biosimilars (2014-2022) ($MN) Table ## Global Erythropoietin Drug M

  • Erythropoietin
  • Asia
  • Europe
  • World
  • Forecast

Erythropoietin Market - Introduction ##.

  • Biopharmaceutical
  • Erythropoietin
  • World
  • Market Size

In addition, major players of the erythropoietin drug, along with their upcoming and anticipated erythropoietin-related products are analyzed to demonstrate how these advances might impact global erythropoietin drug market.

  • Biopharmaceutical
  • Erythropoietin
  • World
  • Forecast

European Erythropoietin Market Outlook 2022 ##.

  • Biopharmaceutical
  • Erythropoietin
  • Europe
  • Market Size
  • Global erythropoietin drugs market
  • ERYTHROPOIETIN DRUGS MARKET IN JAPAN 2014-2019 ($ MILLIONS)
  • Erythropoietin
  • Japan
  • Chugai Pharmaceutical Co., Ltd.
  • Kissei Pharmaceutical Co., Ltd.
  • Kyowa Hakko Kirin Co., Ltd.

Global Erythropoietin Market Outlook 2020 ##.

  • Biopharmaceutical
  • Erythropoietin
  • World
  • Forecast
  • Market Size

This enables Biocon to enhance its erythropoietin drugs portfolio.

  • Biopharmaceutical
  • Erythropoietin
  • Forecast
  • Erythropoietin: An overview
  • Global erythropoietin market
  • Erythropoietin
  • China
  • Market Size
  • 3SBio Inc.
  • Kyowa Hakko Kirin Co., Ltd.

Erythropoietin Drugs - Market Overview ##.

  • Biopharmaceutical
  • Erythropoietin
  • Pathology
  • World

Erythropoietin (EPO), Granulocyte Colony-Stimulating Factor (GCSF), Insulin, Interferon, Interleukin, Monoclonal Antibodies (MAb), Nerve GF, Somatropin, and Others.............. ## Biosimilars.............. ## Table ##: Biosimilars Market by Segment Worldwide (2014) - Percentage Share Breakdown

  • Erythropoietin
  • Infectious Disease
  • World
  • Market Shares
  • Market Size

Hoffmann-La Roche Ltd., Johnson & Johnson Ltd., Lonza Group Ltd., Pfizer, Inc., Sanofi S. A., and Others.............. ## Table ##: Market Shares of Leading Erythropoietin (EPO) Companies in China (2014) - Percentage Share Breakdown by Value for ##SBio, Inc., Beijing Four Rings Biopharmac

  • Erythropoietin
  • China
  • World
  • Demand
  • Market Shares

Hoffmann-La Roche Ltd., Johnson & Johnson Ltd., Lonza Group Ltd., Pfizer, Inc., Sanofi S. A., and Others.............. ## Table ##: Market Shares of Leading Erythropoietin (EPO) Companies in China (2014) - Percentage Share Breakdown by Value for ##SBio, Inc., Beijing Four Rings Biopharmac

  • Biopharmaceutical
  • Erythropoietin
  • World
  • Demand
  • Market Shares

Erythropoietin (EPO), Granulocyte Colony-Stimulating Factor (GCSF), Insulin, Interferon, Interleukin, Monoclonal Antibodies (MAb), Nerve GF, Somatropin, and Others.............. ## Biosimilars.............. ## Table ##: Biosimilars Market by Segment Worldwide (2014) - Percentage Share Breakdown

  • Erythropoietin
  • United States
  • World
  • Demand
  • Market Shares

MARKET OVERVIEW.............. ## Therapeutic Biologics.............. ## Table ##: Therapeutic Biologics Market by Type in China (2014) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Granulocyte Colony-Stimulating Factor (GCSF), Insulin, Interferon, Interleukin, Monoclonal Antib

  • Biopharmaceutical
  • Erythropoietin
  • China
  • United States
  • Market Shares
  • PEGYLATED ERYTHROPOIETIN - DRUG PROFILE
  • ERYTHROPOIETIN - DRUG PROFILE
  • Chronic Disease
  • Erythropoietin
  • United States
  • World
  • Product Initiative
  • 8.4 ERYTHROPOIETIN (EPO)
  • PEGYLATED PROTEINS MARKET SIZE FOR ERYTHROPOIETIN, BY REGION, 2014-2021 (USD MILLION)
  • Erythropoietin
  • Interferon
  • North America
  • World
  • JenKem Technology Co., Ltd
  • 1.1 ERYTHROPOIETIN
  • ERYTHROPOIETIN RESPONSE TO HYPOXIA
  • Erythropoietin
  • Asia
  • World
  • Market Size
  • Roche Group
  • ERYTHROPOIETIN - DRUG PROFILE
  • PEGYLATED ERYTHROPOIETIN - DRUG PROFILE
  • Blood Disease
  • Erythropoietin
  • Pharmaceutical
  • United States
  • Product Initiative
  • Clinical Trial profile. 7 Trial Title
  • Clinical Trial profile. 9 Trial Title
  • Blood Disease
  • Clinical Trial
  • Erythropoietin
  • Therapy
  • Amgen Inc.
  • Official Title
  • Official Title
  • Blood Disease
  • Clinical Trial
  • Erythropoietin
  • Therapy
  • F. Hoffmann-La Roche Ltd.
  • 3. GDCT ID is the unique ID of GlobalData's Pharma Intelligence Center clinical trial database
  • 5. All the trials included are unique trials.
  • Blood Disease
  • Clinical Trial
  • Erythropoietin
  • Therapy
  • F. Hoffmann-La Roche Ltd.
  • BBT-009
  • Bolder Biotechnology, Inc. - Preclinical, 2016
  • Erythropoietin
  • R&D
  • Research And Development
  • United States
  • Bolder BioTechnology, Inc.
  • EPOETIN ALFA - DRUG PROFILE
  • PEG-EPO - DRUG PROFILE
  • Blood Disease
  • Erythropoietin
  • United States
  • Product Initiative
  • FibroGen, Inc.
  • EPOETIN ALFA - DRUG PROFILE
  • PEG-EPO - DRUG PROFILE
  • Erythropoietin
  • Research And Development
  • United States
  • Product Initiative
  • FibroGen, Inc.
  • Product Description
  • Intas Pharmaceuticals Ltd. - Phase III, 2015
  • Erythropoietin
  • Therapy
  • World
  • Product Initiative
  • Intas Pharmaceuticals Ltd.
  • ERYTHROPOIETIN MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • NORTH AMERICA COMMANDED THE LARGEST SHARE OF THE ERYTHROPOIETIN
  • Erythropoietin
  • Proteomics
  • World
  • Market Size
  • Thermo Fisher Scientific, Inc.
  • Research and Development Brief
  • Mechanism of Action
  • Erythropoietin
  • United States
  • World
  • Product Initiative
  • FibroGen, Inc.